Report cover image

Global Oral Hair Loss Medication Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20278056

Description

Summary

According to APO Research, The global Oral Hair Loss Medication market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oral Hair Loss Medication include Zhejiang Xianju Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Merck & Co., Pfizer, China Resources Double-crane Pharmaceutical, Teva Pharmaceuticals, Sandoz, Organon Pharma and Marksans Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Hair Loss Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oral Hair Loss Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Hair Loss Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Hair Loss Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Hair Loss Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Hair Loss Medication sales, projected growth trends, production technology, application and end-user industry.

Oral Hair Loss Medication Segment by Company

Zhejiang Xianju Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Merck & Co.
Pfizer
China Resources Double-crane Pharmaceutical
Teva Pharmaceuticals
Sandoz
Organon Pharma
Marksans Pharma
Aurobindo Pharma
Oral Hair Loss Medication Segment by Type

Finasteride
Minoxidil
Oral Hair Loss Medication Segment by Application

Male Hair Loss
Female Hair Loss
Oral Hair Loss Medication Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Hair Loss Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Hair Loss Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Hair Loss Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Hair Loss Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Hair Loss Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Hair Loss Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Hair Loss Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Oral Hair Loss Medication Market Size, 2020 VS 2024 VS 2031
1.3 Global Oral Hair Loss Medication Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oral Hair Loss Medication Sales Estimates and Forecasts (2020-2031)
1.5 Global Oral Hair Loss Medication Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oral Hair Loss Medication Market Dynamics
2.1 Oral Hair Loss Medication Industry Trends
2.2 Oral Hair Loss Medication Industry Drivers
2.3 Oral Hair Loss Medication Industry Opportunities and Challenges
2.4 Oral Hair Loss Medication Industry Restraints
3 Oral Hair Loss Medication Market by Manufacturers
3.1 Global Oral Hair Loss Medication Revenue by Manufacturers (2020-2025)
3.2 Global Oral Hair Loss Medication Sales by Manufacturers (2020-2025)
3.3 Global Oral Hair Loss Medication Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oral Hair Loss Medication Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral Hair Loss Medication Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral Hair Loss Medication Manufacturers, Product Type & Application
3.7 Global Oral Hair Loss Medication Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral Hair Loss Medication Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Hair Loss Medication Players Market Share by Revenue in 2024
3.8.3 2024 Oral Hair Loss Medication Tier 1, Tier 2, and Tier 3
4 Oral Hair Loss Medication Market by Type
4.1 Oral Hair Loss Medication Type Introduction
4.1.1 Finasteride
4.1.2 Minoxidil
4.2 Global Oral Hair Loss Medication Sales by Type
4.2.1 Global Oral Hair Loss Medication Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oral Hair Loss Medication Sales by Type (2020-2031)
4.2.3 Global Oral Hair Loss Medication Sales Market Share by Type (2020-2031)
4.3 Global Oral Hair Loss Medication Revenue by Type
4.3.1 Global Oral Hair Loss Medication Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oral Hair Loss Medication Revenue by Type (2020-2031)
4.3.3 Global Oral Hair Loss Medication Revenue Market Share by Type (2020-2031)
5 Oral Hair Loss Medication Market by Application
5.1 Oral Hair Loss Medication Application Introduction
5.1.1 Male Hair Loss
5.1.2 Female Hair Loss
5.2 Global Oral Hair Loss Medication Sales by Application
5.2.1 Global Oral Hair Loss Medication Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oral Hair Loss Medication Sales by Application (2020-2031)
5.2.3 Global Oral Hair Loss Medication Sales Market Share by Application (2020-2031)
5.3 Global Oral Hair Loss Medication Revenue by Application
5.3.1 Global Oral Hair Loss Medication Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oral Hair Loss Medication Revenue by Application (2020-2031)
5.3.3 Global Oral Hair Loss Medication Revenue Market Share by Application (2020-2031)
6 Global Oral Hair Loss Medication Sales by Region
6.1 Global Oral Hair Loss Medication Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oral Hair Loss Medication Sales by Region (2020-2031)
6.2.1 Global Oral Hair Loss Medication Sales by Region (2020-2025)
6.2.2 Global Oral Hair Loss Medication Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral Hair Loss Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oral Hair Loss Medication Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oral Hair Loss Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oral Hair Loss Medication Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral Hair Loss Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oral Hair Loss Medication Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oral Hair Loss Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oral Hair Loss Medication Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oral Hair Loss Medication Revenue by Region
7.1 Global Oral Hair Loss Medication Revenue by Region
7.1.1 Global Oral Hair Loss Medication Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oral Hair Loss Medication Revenue by Region (2020-2025)
7.1.3 Global Oral Hair Loss Medication Revenue by Region (2026-2031)
7.1.4 Global Oral Hair Loss Medication Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oral Hair Loss Medication Revenue (2020-2031)
7.2.2 North America Oral Hair Loss Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oral Hair Loss Medication Revenue (2020-2031)
7.3.2 Europe Oral Hair Loss Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral Hair Loss Medication Revenue (2020-2031)
7.4.2 Asia-Pacific Oral Hair Loss Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oral Hair Loss Medication Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oral Hair Loss Medication Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Zhejiang Xianju Pharmaceutical
8.1.1 Zhejiang Xianju Pharmaceutical Comapny Information
8.1.2 Zhejiang Xianju Pharmaceutical Business Overview
8.1.3 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Product Portfolio
8.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
8.2 Shanxi Ante Bio-pharmaceutical
8.2.1 Shanxi Ante Bio-pharmaceutical Comapny Information
8.2.2 Shanxi Ante Bio-pharmaceutical Business Overview
8.2.3 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Product Portfolio
8.2.5 Shanxi Ante Bio-pharmaceutical Recent Developments
8.3 Merck & Co.
8.3.1 Merck & Co. Comapny Information
8.3.2 Merck & Co. Business Overview
8.3.3 Merck & Co. Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merck & Co. Oral Hair Loss Medication Product Portfolio
8.3.5 Merck & Co. Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Oral Hair Loss Medication Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 China Resources Double-crane Pharmaceutical
8.5.1 China Resources Double-crane Pharmaceutical Comapny Information
8.5.2 China Resources Double-crane Pharmaceutical Business Overview
8.5.3 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Product Portfolio
8.5.5 China Resources Double-crane Pharmaceutical Recent Developments
8.6 Teva Pharmaceuticals
8.6.1 Teva Pharmaceuticals Comapny Information
8.6.2 Teva Pharmaceuticals Business Overview
8.6.3 Teva Pharmaceuticals Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Teva Pharmaceuticals Oral Hair Loss Medication Product Portfolio
8.6.5 Teva Pharmaceuticals Recent Developments
8.7 Sandoz
8.7.1 Sandoz Comapny Information
8.7.2 Sandoz Business Overview
8.7.3 Sandoz Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Sandoz Oral Hair Loss Medication Product Portfolio
8.7.5 Sandoz Recent Developments
8.8 Organon Pharma
8.8.1 Organon Pharma Comapny Information
8.8.2 Organon Pharma Business Overview
8.8.3 Organon Pharma Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Organon Pharma Oral Hair Loss Medication Product Portfolio
8.8.5 Organon Pharma Recent Developments
8.9 Marksans Pharma
8.9.1 Marksans Pharma Comapny Information
8.9.2 Marksans Pharma Business Overview
8.9.3 Marksans Pharma Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Marksans Pharma Oral Hair Loss Medication Product Portfolio
8.9.5 Marksans Pharma Recent Developments
8.10 Aurobindo Pharma
8.10.1 Aurobindo Pharma Comapny Information
8.10.2 Aurobindo Pharma Business Overview
8.10.3 Aurobindo Pharma Oral Hair Loss Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Aurobindo Pharma Oral Hair Loss Medication Product Portfolio
8.10.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oral Hair Loss Medication Value Chain Analysis
9.1.1 Oral Hair Loss Medication Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Hair Loss Medication Production Mode & Process
9.2 Oral Hair Loss Medication Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Hair Loss Medication Distributors
9.2.3 Oral Hair Loss Medication Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us